• Like
  • Comment
  • Favorite

Cutia Therapeutics CEO Buys 8,000 Shares

MT Newswires Live2024-10-14

Cutia Therapeutics' (HKG:2487) chief executive officer Zhang Lele purchased a total of 8,000 shares in the open market with her personal funds on Oct. 9 and 10, according to a Monday filing with the Hong Kong bourse.

Zhang bought back the shares for a total of HK$102,816, with an average share price of HK$12.85 apiece.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
errorbox banner

抱歉,当前请求异常(-1)

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial